• Pifithrin-α: Advanced Insights into p53 Inhibition and Ce...

  2025-09-26

  Explore the multifaceted role of Pifithrin-α as a p53 inhibitor in apoptosis research and cell cycle modulation. This article provides a unique, in-depth analysis of Pifithrin-α's mechanisms and cutting-edge applications in DNA damage response, cancer therapy mitigation, and neuroprotection.

• PD 0332991 (Palbociclib) HCl: Unraveling CDK4/6 Inhibitio...

  2025-09-25

  Explore the advanced mechanisms of PD 0332991 (Palbociclib) HCl, a selective CDK4/6 inhibitor, and its role in cell cycle G1 phase arrest, tumor growth suppression, and mitochondrial apoptosis. This article offers a novel synthesis of CDK inhibition and apoptotic signaling, providing new insights for breast cancer and multiple myeloma research.

• Pseudo-modified Uridine Triphosphate: Transforming mRNA S...

  2025-09-24

  Explore the advanced scientific principles of pseudo-modified uridine triphosphate (Pseudo-UTP) and its pivotal role in RNA stability enhancement and mRNA vaccine development. This article offers a unique, in-depth analysis of the molecular mechanisms and translational applications that set Pseudo-UTP apart in gene therapy and synthetic biology.

• ABT-737: Unveiling Mitochondrial Apoptosis Signaling Beyo...

  2025-09-23

  This article explores ABT-737, a BH3 mimetic BCL-2 protein inhibitor, as a molecular tool for dissecting intrinsic mitochondrial apoptosis signaling in cancer. We highlight novel findings linking BCL-2/BAX interaction disruption with recent discoveries on apoptosis initiation, providing advanced guidance for researchers in small-cell lung cancer and AML studies.

• Nebivolol Hydrochloride: Selective β1 Blocker in Cardiova...

  2025-09-22

  Explore the scientific applications of Nebivolol hydrochloride, a highly selective β1-adrenoceptor antagonist, in cardiovascular pharmacology and β1-adrenergic receptor signaling research. This article examines its specificity, utility in mechanistic studies, and recent findings related to receptor pathway screening.

• ABT-263 (Navitoclax): Dissecting Nuclear-Mitochondrial Ap...

  2025-09-19

  Explore how ABT-263 (Navitoclax), a potent Bcl-2 family inhibitor, enables advanced mechanistic studies of nuclear-mitochondrial apoptotic signaling in cancer biology. This article highlights emerging insights into caspase-dependent apoptosis research, integrating recent discoveries about RNA Pol II-driven cell death pathways.

• Maximizing mRNA Delivery and Bioluminescent Reporting wit...

  2025-09-18

  Explore how EZ Cap™ Firefly Luciferase mRNA with Cap 1 structure advances mRNA delivery, translation efficiency assays, and in vivo bioluminescence imaging. This comprehensive review highlights the molecular features, experimental applications, and recent delivery innovations for robust gene regulation reporter assays.

• The lactam emerged as lead candidate due to its

  2025-03-03

  

  The lactam (6) emerged as lead candidate due to its high selectivity, outstanding potency (against ALK or in clinically known ALK mutants), low in vitro clearance, and low efflux potential. The lactam (6) was selected for further profiling against the resistant ALK mutants. Preclinical rat pharmacok

• In conclusion phenolic hydroxyl was introduced not

  2025-03-03

  

  In conclusion, phenolic hydroxyl was introduced not only to C3 side chain but also to C6 or C7 position of the quinoxalinone core, resulting in a new group of ARIs candidates exhibiting antioxidant activity. Biological activity tests suggested that compounds were not only sufficient to inhibit ALR2

• The present study determined the effect of DCA

  2025-03-03

  

  The present study determined the effect of DCA on VSMC calcification in vitro and in atherosclerotic ApoE-/- mice in vivo. We found that Membrane impermeable dye non-toxic concentrations of DCA, did not affect VSMC viability, induced calcification of VSMC in culture and increased atherosclerotic vas

• With one exception all receptors for dopamine DA serotonin h

  2025-03-03

  

  With one exception, all receptors for dopamine (DA), serotonin (5-hydroxytryptamine, 5-HT), and norepinephrine are metabotropic receptors. The five metabotropic DA receptors (D1–D5) in the CNS are involved in motivation, pleasure, cognition, learning, memory, fine motor control, and modulate neuroen

• G has been shown to participate in various MT

  2025-03-03

  

  Gβγ has been shown to participate in various MT-dependent processes such as cell growth and differentiation [15,[21], [22], [23], [24], [25], [26]]. G-protein β-subunit anti-sense oligonucleotides have been shown to inhibit cell proliferation and cause disorganization of the mitotic spindle in mamma

• ionophore In conclusion we have shown that mGlu

  2025-03-03

  

  In conclusion, we have shown that mGlu7 receptors negatively regulate α1-adrenergic receptor signalling in heterologous expression systems, ionophore tissue and living animals. This interaction might represent a protective mechanism aimed at restraining an excessive activation of noradrenergic tran

• The synthetic route to M

  2025-03-03

  

  The synthetic route to M100907 developed by Rice was utilized, however, the chiral resolution was carried out at an earlier stage to provide the possibility of introducing different substituents onto the piperidinyl group. The conditions for this resolution were different from previously reported.

• False positivity of Anti AChR Ab titers

  2025-03-03

  

  False positivity of Anti-AChR Ab titers, due to cross reactivity with bungarotoxin, has previously been demonstrated. One such study reported that patients with amyotrophic lateral sclerosis, who had received long term snake venom therapy, had developed antibodies to bungarotoxin and hence demonstra

14722 records 1/982 page Next 12345 下5页 Last page